Spiro [1-azabicyclo [2.2.2] octan3,5'-oxazolidin]-2'-one derivatives with affinity to the alpha7 nicotinic acetylcholine receptor

Details for Australian Patent Application No. 2004255920 (hide)

International Classifications

Event Publications

2 February 2006 PCT application entered the National Phase

PCT publication WO2005/005435 Priority application(s): WO2005/005435

10 April 2008 Amendment Made

The nature of the amendment is: Amend the invention title to read Spiro [1-azabicyclo [2.2.2] octan3,5'-oxazolidin]-2'-one derivatives with affinity to the alpha7 nicotinic acetylcholine receptor 2005

15 May 2008 Application Accepted

Published as AU-B-2004255920

11 September 2008 Standard Patent Sealed

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.